Find a Commonwealth Resource
Pentobarbital sodium
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Pentobarbital Sodium is a prescription injectable solution (50 mg/mL) used for intramuscular or intravenous administration. Manufactured by Hikma Pharmaceuticals USA Inc., it's a DEA Schedule II controlled substance for medical purposes like sedation or anesthesia. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Pentobarbital sodium
Access the FDA dataset for Pentobarbital sodium — ANDA 203619 submitted by Mylan Institutional LLC
Modified Apr 29, 2026